[Elsevier] FOUR PAPERS FROM LANCET

Waltersport Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-03 17:38
Reward120points

1. Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes

DOI: 10.1016/S0140-6736(26)01247-X

2. Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes

DOI: 10.1016/S0140-6736(26)01247-X

3. Psoriasis


DOI: 10.1016/S0140-6736(26)00349-1

4. Type 1 diabetes in older populations

DOI: 10.1016/S2213-8587(26)00154-3


Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
vhernandez Post time Half hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    2065


Return to the list